Impacts of the Medical Arms Race on Medical Expenses: a Public Hospital-based Study in Shenzhen, China, During 2009-2013

Overview

Journal Cost Eff Resour Alloc

Publisher Biomed Central

Date 2022 Dec 25

PMID 36567370

Authors

Paicheng Liu

Xue Gong

Qianhui Yao

Qiong Liu

Affiliations

Soon will be listed here.

Abstract

Background: Has the medical arms race (MAR) increased healthcare expenditures? Existing literature has yet to draw a consistent conclusion. Hence, this study aims to reexamine the relationship between the MAR and medical expenses by the data from public hospitals in Shenzhen, China, during the period of 2009 to 2013.

Methods: This study's data were collected through panel datasets spanning 2009 to 2013 from the Shenzhen Statistical Yearbook, Shenzhen Health Statistical Yearbook, and annual reports from the Shenzhen Municipal Health Commission. The Herfindahl-Hirschman index and hierarchical linear modeling were combined for empirical analysis.

Results: The MAR's impact on medical examination fees differed during the inpatient and outpatient stages. Further analysis verified that the MAR had the most significant impact on outpatient examination fees. Due to the characteristics of China's medical system, government regulations in the healthcare market may consequently accelerate the MAR among public hospitals. Strict government regulations on the medical system have also promoted increased medical examination costs to some extent. Once medical service prices are under strict administrative control, only drug and medical examination fees are the primary forms of extra income for hospitals. After the proportion of drug fees is further regulated, medical examinations will then become another staple method to generate extra revenue. These have distorted Chinese public hospitals' medical fees, which completely differ from those in other countries.

Conclusion: The government should confirm that they have allocated sufficient financial investments for public hospitals; otherwise, the competition among hospitals will transfer the burden to patients, and especially to those who can afford to pay for care. A core task for public hospitals involves providing safer, less expensive, and more reliable medical services.

References

Zang W, Zhou M, Zhao S . Deregulation and pricing of medical services: a policy experiment based in China. BMC Health Serv Res. 2021; 21(1):501. PMC: 8146237. DOI: 10.1186/s12913-021-06525-x. View

Ellis R, Fiebig D, Johar M, Jones G, Savage E . Explaining health care expenditure variation: large-sample evidence using linked survey and health administrative data. Health Econ. 2013; 22(9):1093-110. DOI: 10.1002/hec.2916. View

Eggleston K, Ling L, Qingyue M, Lindelow M, Wagstaff A . Health service delivery in China: a literature review. Health Econ. 2007; 17(2):149-65. DOI: 10.1002/hec.1306. View

Pan J, Liu G . The determinants of Chinese provincial government health expenditures: evidence from 2002-2006 data. Health Econ. 2011; 21(7):757-77. DOI: 10.1002/hec.1742. View

Eggleston K, Lu M, Li C, Wang J, Yang Z, Zhang J . Comparing public and private hospitals in China: evidence from Guangdong. BMC Health Serv Res. 2010; 10:76. PMC: 2858143. DOI: 10.1186/1472-6963-10-76. View

. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018; 391(10136):2236-2271. PMC: 5986687. DOI: 10.1016/S0140-6736(18)30994-2. View

Tang C, Xu J, Zhang M . The choice and preference for public-private health care among urban residents in China: evidence from a discrete choice experiment. BMC Health Serv Res. 2016; 16(1):580. PMC: 5070360. DOI: 10.1186/s12913-016-1829-0. View

Dranove D, Shanley M, Simon C . Is hospital competition wasteful?. Rand J Econ. 1993; 23(2):247-62. View

Berenson R, Bodenheimer T, Pham H . Specialty-service lines: salvos in the new medical arms race. Health Aff (Millwood). 2006; 25(5):w337-43. DOI: 10.1377/hlthaff.25.w337. View

10.

Noether M . Competition among hospitals. J Health Econ. 1988; 7(3):259-84. DOI: 10.1016/0167-6296(88)90028-8. View

11.

Robinson J, Luft H . The impact of hospital market structure on patient volume, average length of stay, and the cost of care. J Health Econ. 1985; 4(4):333-56. DOI: 10.1016/0167-6296(85)90012-8. View

12.

Liu X, Liu Y, Chen N . The Chinese experience of hospital price regulation. Health Policy Plan. 2000; 15(2):157-63. DOI: 10.1093/heapol/15.2.157. View

13.

Chi-Man Yip W, Hsiao W, Meng Q, Chen W, Sun X . Realignment of incentives for health-care providers in China. Lancet. 2010; 375(9720):1120-30. DOI: 10.1016/S0140-6736(10)60063-3. View

14.

Eggleston K, Yip W . Hospital competition under regulated prices: application to urban health sector reforms in China. Int J Health Care Finance Econ. 2004; 4(4):343-68. DOI: 10.1023/B:IHFE.0000043762.33274.4f. View

15.

Oh E, Imanaka Y, Evans E . Determinants of the diffusion of computed tomography and magnetic resonance imaging. Int J Technol Assess Health Care. 2005; 21(1):73-80. DOI: 10.1017/s0266462305050099. View

16.

Hay J . Hospital cost drivers: an evaluation of 1998-2001 state-level data. Am J Manag Care. 2003; 9 Spec No 1:SP13-24. View

17.

Blumenthal D, Hsiao W . Privatization and its discontents--the evolving Chinese health care system. N Engl J Med. 2005; 353(11):1165-70. DOI: 10.1056/NEJMhpr051133. View

18.

McGuire T, Pauly M . Physician response to fee changes with multiple payers. J Health Econ. 1990; 10(4):385-410. DOI: 10.1016/0167-6296(91)90022-f. View

19.

Manning W, NEWHOUSE J, Duan N, Keeler E, Leibowitz A, Marquis M . Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987; 77(3):251-77. View

20.

Allen P, Cao Q, Wang H . Public hospital autonomy in China in an international context. Int J Health Plann Manage. 2013; 29(2):141-59. DOI: 10.1002/hpm.2200. View